Received Jul 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
longer interval between doses; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 52-year-old female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 29-NOV-2023). On an unknown date, the patient did not receive the 2nd dose of Shingrix.The patient experienced incomplete course of vaccination (Verbatim: longer interval between doses). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 15-JUL-2025 Pharmacist reported a patient received her first dose of Shingrix in 2023 and now wanted to come in to get a dose. Patient had not yet received second dose. The lot and expiration date of 1st dose was not available from healthcare professional. The reporter consented to follow up. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.